MALARA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 1.010
EU - Europa 862
AS - Asia 530
OC - Oceania 4
AF - Africa 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.413
Nazione #
US - Stati Uniti d'America 996
CN - Cina 496
IE - Irlanda 317
IT - Italia 149
FI - Finlandia 107
DE - Germania 104
UA - Ucraina 62
SE - Svezia 61
GB - Regno Unito 30
SG - Singapore 18
BE - Belgio 17
CA - Canada 13
FR - Francia 8
JP - Giappone 8
CZ - Repubblica Ceca 4
NZ - Nuova Zelanda 4
IN - India 3
MU - Mauritius 3
CL - Cile 2
AM - Armenia 1
BD - Bangladesh 1
BR - Brasile 1
EU - Europa 1
HK - Hong Kong 1
IR - Iran 1
NL - Olanda 1
PA - Panama 1
PL - Polonia 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 2.413
Città #
Dublin 316
Chandler 242
Nanjing 126
Jacksonville 113
Pavia 80
Beijing 76
Ann Arbor 68
Boardman 68
Ashburn 66
Nanchang 57
Helsinki 48
Shenyang 46
Princeton 43
Lawrence 42
Medford 41
Changsha 37
Wilmington 37
Tianjin 35
Hebei 34
Shanghai 26
Jiaxing 25
Brussels 17
New York 14
Hangzhou 13
Woodbridge 11
Toronto 10
Falls Church 8
Tokyo 8
Fairfield 7
Singapore 7
Jinan 6
Milan 6
Munich 6
Washington 6
Verona 5
Dallas 4
Hamilton 4
Los Angeles 4
Norwalk 4
San Francisco 4
Seattle 4
Falkenstein 3
Fiesole 3
Hanover 3
Leawood 3
Redwood City 3
Augusta 2
Brno 2
Buccinasco 2
Chongqing 2
Clifton 2
Des Moines 2
Olomouc 2
Orange 2
Piscataway 2
Pune 2
Verrua Po 2
Zhengzhou 2
Americana 1
Amsterdam 1
Ardabil 1
Berlin 1
Borås 1
Casorate Sempione 1
Castelli Calepio 1
Castiglione Olona 1
Central 1
Delhi 1
Gallarate 1
Guangzhou 1
Houston 1
Irpin 1
Markham 1
Melilli 1
Menlo Park 1
Missaglia 1
Naples 1
Ningbo 1
Ottawa 1
Padova 1
Phoenix 1
Piacenza 1
Redmond 1
Rockville 1
Saint Petersburg 1
Sassari 1
Taizhou 1
Tappahannock 1
Torre del Greco 1
Tradate 1
Turin 1
Vigevano 1
Würzburg 1
Yerevan 1
Totale 1.849
Nome #
Biocompatibility of functionalized boron phosphate (BPO4) nanoparticles for boron neutron capture therapy (BNCT) application 97
Adhesion to different collagens modulates megakaryocyte development 93
Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A. 83
Folic acid-conjugated 4-amino-phenylboronate, a boron-containing compound designed for boron neutron capture therapy, is an unexpected agonist for human neutrophils and platelets 81
The interaction of adenosine diphosphate with P2Y13 regulates in vitro proplatelet formation from human megakaryocytes 81
Fibronectin and megakaryocyte development 79
Fibronectin Is Dispensable for An Efficient Bone Marrow Thrombopoiesis, but Affects Platelet Size in Mice 77
Extracellular matrix structure and nano-mechanics determine megakaryocyte function 75
BERNARD SOULIER SYNDROME IN A PATIENT AFFECTED BY KLINEFELTER DISEASE: NOVEL A386G HOMOZYGOUS MUTATION OF GPIB alpha GENE WITH ANOMALOUS BEHAVIOUR 74
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. 70
Outside-in signalling generated by a constitutively activated integrin αIIbβ3 impairs proplatelet formation in human megakaryocytes. 70
The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control 67
Blood Platelet Production and Morphology. 66
Megakaryocytes Contribute to the Bone Marrow-MatrixEnvironment by Expressing Fibronectin, Type Iv Collagen and Laminin 66
Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis 65
Thrombopoietin/TGF-β1 loop regulates megakaryocyte extracellular matrix component synthesis 64
THE D1424N AND R1933X MUTATIONS OF MYH9 CAUSE THROMBOCYTOPENIA THROUGH LOSS OF REGULATION OF PROPLATELET FORMATION BY TYPE I COLLAGEN. 63
Alternatively spliced fibronectin extra domain A is required for hemangiogenic recovery upon bone marrow chemotherapy 62
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment 61
Hyaluronan based hydrogels provide an improved model to study megakaryocyte-matrix interactions 58
EXTRACELLULAR MATRIX NANO-MECHANICS DETERMINE MEGAKARYOCITE FUNCTION. 57
Extracellular matrix nano-mechanics determines megakaryocyte function 57
The D1424N and R1933X mutations of MYH9 result in an altered proplatelet formation by human megakaryocytes 55
Megakaryocytes derived from patients with the classical form of Bernard-Soulier syndrome show no ability to extend proplatelets in vitro. 54
Creation and implantation of acellular rat renal ECM-based scaffolds 54
A A386G biallelic GPIb alpha gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis. 54
EDA fibronectin–TLR4 axis sustains megakaryocyte expansion and inflammation in bone marrow fibrosis 54
Constitutively released adenosine diphosphate regulates proplatelet formation by human megakaryocytes 53
The plant hormone abscisic acid is a prosurvival factor in human and murine megakaryocytes 53
Brief Report: Alternative Splicing of Extra Domain A (EIIIA) of Fibronectin Plays a Tissue-Specific Role in Hematopoietic Homeostasis 50
EDA Fibronectin-TLR4 Axis Sustains Megakaryocyte Expansion and Inflammation during Bone Marrow Fibrosis Progression. 49
Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies 46
The structure of extracellular matrices influences proplatelet formation by human megakaryocyte 41
New Mechanisms of Megakaryocyte-Matrix Interaction within Bone Marrow Environment 41
Bone marrow microenvironment of MPN cells 39
Mechanisms of platelet release: in vivo studies and in vitro modeling 38
Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver 36
Low penetrance COL5A1 variants in a young patient with intracranial aneurysm and very mild signs of Ehlers-Danlos syndrome 35
Proplatelet formation in heterozygous Bernard-Soulier syndrome type Bolzano. 30
Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation. 27
Sub-Cellular Localization of Metalloproteinases in Megakaryocytes 24
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 24
Elevated plasma EDA fibronectin in primary myelofibrosis is determined by high allele burden of JAK2V617F mutation and strongly predicts splenomegaly progression 22
Bi-allelic variants in the ESAM tight-junction gene cause a neurodevelopmental disorder associated with fetal intracranial hemorrhage 17
Lack of COL6/collagen VI causes megakaryocyte dysfunction by impairing autophagy and inducing apoptosis 16
The α2-adrenergic receptor pathway modulating depression influences the risk of arterial thrombosis associated with BDNFVal66Met polymorphism 15
Inflammation and bone marrow fibrosis: novel immunotherapeutic targets 8
Megakaryocytes in the lung: guests or ghosts? 7
Megakaryocyte Cytoskeletal Proteins in Platelet Biogenesis and Diseases 4
Totale 2.512
Categoria #
all - tutte 9.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020369 0 222 0 17 2 13 11 15 17 49 19 4
2020/2021212 32 12 4 30 1 21 4 29 23 28 23 5
2021/2022264 6 2 4 34 9 8 9 13 15 27 24 113
2022/2023749 84 68 2 60 69 58 3 46 329 8 15 7
2023/2024299 37 62 13 19 20 74 8 22 4 10 13 17
2024/202590 33 57 0 0 0 0 0 0 0 0 0 0
Totale 2.512